Improvement of Executive Functions With the CO-OP Method in the Adult Subject After Stroke (FéCO-OPSA)
Cerebrovascular Accident
About this trial
This is an interventional treatment trial for Cerebrovascular Accident focused on measuring CO-OP, executive functions, stroke, single-case experimental designs, transfer of knowledge, sens of self efficacy
Eligibility Criteria
Inclusion Criteria:
- Stroke responsible for a dysexecutive syndrome authenticated by the GREFEX battery
- Stroke more than 6 months old (chronic phase)
- Social security affiliation
- Signing of a free and informed consent following clear and detailed information.
Exclusion Criteria:
- Disorder of comprehension objectified by the - LAnguage Screening Test (LAST) (minimum score 4/8 in expression and 6/7 in comprehension)
- Significant anosognosia of dysexecutive syndrome
- Pregnant women
- Neurological condition other than stroke or psychiatric disorder
- Patient following a rehabilitation with a liberal therapist targeting executive functions during the period of participation in the study.
Sites / Locations
- University Hospital of Toulouse
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
CO-OP Arm (early phase A)
CO-OP Arm (mid phase A)
CO-OP Arm (late phase A)
Patients will be integrated during the traditional day hospitalization follow-up, at the rate of 3 sessions per week. The patient will have 2 phases : phase A: CO-OP treatment during 6 week and phase B : without specific treatment during 3 weeks.
Patients will be integrated during the traditional day hospitalization follow-up, at the rate of 3 sessions per week. The patient will have 2 phases : phase A: CO-OP treatment during 6 week and phase B : without specific treatment during 2.5 weeks.
Patients will be integrated during the traditional day hospitalization follow-up, at the rate of 3 sessions per week. The patient will have 2 phases : phase A: CO-OP treatment during 6 week and phase B : without specific treatment during 2 weeks.